Sun Pharma Gets Green Signal from FDA for Wellbutrin

by Rajshri on  April 8, 2010 at 9:52 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

 Sun Pharma Gets Green Signal from FDA for Wellbutrin
Indian drugmaker Sun Pharmaceuticals has announced that it has got approval from the U.S. regulatory authorities to market a generic version of GlaxoSmithKline's Wellbutrin SR extended release tablets.

The company, which is in trouble in Israel, said that the FDA approved its application to market a generic version of Wellbutrin on Thursday.

Wellbutrin is an antidepressant medication and works in the brain to treat major depressive disorder and seasonal affective disorder


Source: Medindia
RAS

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive